Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor

RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients

(2014) Viera Kajabova et al.   Translational Oncology

Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers

(2013) O. Brouckaert et al.   ANNALS OF ONCOLOGY

Genetic and epigenetic analysis of putative breast cancer stem cell models

(2013) Marija Balic et al.   BMC CANCER

Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells

(2013) Man-Tat Lau et al.   PLoS One

The modulatory effect of cell-cell contact on the tumourigenic potential of pre-malignant epithelial cells: a computational exploration

(2012) D. C. Walker et al.   Journal of the Royal Society Interface

DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status

(2010) James M. Flanagan et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition

(2010) Yvonne L Chao et al.   Molecular Cancer

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via  5-Integrin, which Is a Therapeutic Target

(2008) K. Sawada et al.   CANCER RESEARCH